Five-year routine cervical cancer screening rates and intervals in a US health plan

References

• Jemal A, Siegel R, Ward E. et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43–661. Jemal A, Siegel R, Ward E. et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43–66
   PubMed Web of Science ®Google Scholar
• Cervical cancer screening trends, 1992–2000. J Natl Cancer Inst 2003;95:4242. Cervical cancer screening trends, 1992–2000. J Natl Cancer Inst 2003;95:424
   Web of Science ®Google Scholar
• Swan J, Breen N, Coates RJ. et al. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003;97:1528–403. Swan J, Breen N, Coates RJ. et al. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003;97:1528–40
   PubMed Web of Science ®Google Scholar
• Nelson DE, Bland S, Powell-Griner E. et al. State trends in health risk factors and receipt of clinical preventive services among US adults during the 1990s. JAMA 2002;287:2659–674. Nelson DE, Bland S, Powell-Griner E. et al. State trends in health risk factors and receipt of clinical preventive services among US adults during the 1990s. JAMA 2002;287:2659–67
   PubMed Web of Science ®Google Scholar
• Wang SS, Sherman ME, Hildesheim A. et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000. Cancer 2004;100:1035–445. Wang SS, Sherman ME, Hildesheim A. et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000. Cancer 2004;100:1035–44
   PubMed Web of Science ®Google Scholar
• Chan PG, Sung HY, Sawaya GF. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol 2003;102:765–736. Chan PG, Sung HY, Sawaya GF. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol 2003;102:765–73
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia, U.S: Department of Health and Human Services, Centers for Disease Control and Prevention2002 Online: http://apps.nccd.cdc.gov/brfss/Trends/trendchart.asp?qkey=10070&state=US [Last accessed March 6, 2007]7. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia, U.S: Department of Health and Human Services, Centers for Disease Control and Prevention2002 Online: http://apps.nccd.cdc.gov/brfss/Trends/trendchart.asp?qkey=10070&state=US [Last accessed March 6, 2007]
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia, U.S: Department of Health and Human Services, Centers for Disease Control and Prevention2004 Online: http://apps.nccd.cdc.gov/brfss/display.asp?cat=WH&yr=2004&qkey=4426&state=US [Last accessed March 6, 2007]8. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia, U.S: Department of Health and Human Services, Centers for Disease Control and Prevention2004 Online: http://apps.nccd.cdc.gov/brfss/display.asp?cat=WH&yr=2004&qkey=4426&state=US [Last accessed March 6, 2007]
   Google Scholar
• Chu MUse of the Pap Test as a Cancer Screening ToolMedical Expenditure Panel Survey, Statistical Brief #26. Rockville (MD): Agency for Healthcare Research and Quality2001 Online: http://www.meps.ahrq.gov/mepsweb/data_files/publications/st26/stat26.pdf [Last accessed March 6, 2007]9. Chu MUse of the Pap Test as a Cancer Screening ToolMedical Expenditure Panel Survey, Statistical Brief #26. Rockville (MD): Agency for Healthcare Research and Quality2001 Online: http://www.meps.ahrq.gov/mepsweb/data_files/publications/st26/stat26.pdf [Last accessed March 6, 2007]
   Google Scholar
• Rhoades JAAccess to Care and Use of Preventive Services Estimates for the U.S. Civilian Noninstitutionalized Population, Age 18 to 64Medical Expenditure Panel Survey, Statistical Brief #82. Rockville (MD): Agency for Healthcare Research and Quality2002 Online: http://www.meps.ahrq.gov/mepsweb/data_files/publications/st82/stat82.pdf [Last accessed March 6, 2007]10. Rhoades JAAccess to Care and Use of Preventive Services Estimates for the U.S. Civilian Noninstitutionalized Population, Age 18 to 64Medical Expenditure Panel Survey, Statistical Brief #82. Rockville (MD): Agency for Healthcare Research and Quality2002 Online: http://www.meps.ahrq.gov/mepsweb/data_files/publications/st82/stat82.pdf [Last accessed March 6, 2007]
   Google Scholar
• http://progressreport.cancer.gov/doc_detail.asp?pid=1&did=2005&chid=22&coid=217&mid. [Last accessed February 5, 2006], Located at11. http://progressreport.cancer.gov/doc_detail.asp?pid=1&did=2005&chid=22&coid=217&mid. [Last accessed February 5, 2006], Located at
   Google Scholar
• Noller KL, Bettes B, Zinberg S. et al. Cervical cytology screening practices among obstetrician-gynecologists. Obstet Gynecol 2003;102:259–6512. Noller KL, Bettes B, Zinberg S. et al. Cervical cytology screening practices among obstetrician-gynecologists. Obstet Gynecol 2003;102:259–65
   PubMed Web of Science ®Google Scholar
• Ronco G, Cuzick J, Pierotti P. et al. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomized controlled trial. BMJ 2007;335:28–3113. Ronco G, Cuzick J, Pierotti P. et al. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomized controlled trial. BMJ 2007;335:28–31
   PubMed Web of Science ®Google Scholar
• Cuzick J, Sasieni P, Davies P. et al. A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess 1999;3:i–iv, 1–19614. Cuzick J, Sasieni P, Davies P. et al. A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess 1999;3:i–iv, 1–196
   PubMedGoogle Scholar
• Walboomers JM, Jacobs MV, Manos MM. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12–1915. Walboomers JM, Jacobs MV, Manos MM. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12–19
   PubMed Web of Science ®Google Scholar
• Kulasingam SL, Hughes JP, Kiviat NB. et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002;288:1749–5716. Kulasingam SL, Hughes JP, Kiviat NB. et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002;288:1749–57
   PubMed Web of Science ®Google Scholar
• Saslow D, Runowicz CD, Solomon D. et al. American Cancer Society. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342–6217. Saslow D, Runowicz CD, Solomon D. et al. American Cancer Society. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342–62
   PubMed Web of Science ®Google Scholar
• ACOG Committee on Practice Bulletins ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2003;102:417–27. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995)18. ACOG Committee on Practice Bulletins ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2003;102:417–27. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995)
   PubMedGoogle Scholar
• Insinga RP, Glass AG, Rush BB. Pap screening in a U.S. health plan. Cancer Epidemiol Biomarkers Prev 2004;13:355–6019. Insinga RP, Glass AG, Rush BB. Pap screening in a U.S. health plan. Cancer Epidemiol Biomarkers Prev 2004;13:355–60
   PubMed Web of Science ®Google Scholar
• McPhee SJ, Nguyen TT, Shema SJ. et al. Validation of recall of breast and cervical cancer screening by women in an ethnically diverse population. Prev Med 2002;35:463–7320. McPhee SJ, Nguyen TT, Shema SJ. et al. Validation of recall of breast and cervical cancer screening by women in an ethnically diverse population. Prev Med 2002;35:463–73
   PubMed Web of Science ®Google Scholar
• McGovern PG, Lurie N, Margolis KL. et al. Accuracy of self-report of mammography and Pap smear in a low-income urban population. Am J Prev Med 1998;14:201–821. McGovern PG, Lurie N, Margolis KL. et al. Accuracy of self-report of mammography and Pap smear in a low-income urban population. Am J Prev Med 1998;14:201–8
   PubMed Web of Science ®Google Scholar
• Paskett ED, Tatum CM, Mack DW. et al. Validation of self-reported breast and cervical cancer screening tests among low-income minority women. Cancer Epidemiol Biomarkers Prev 1996;5:721–622. Paskett ED, Tatum CM, Mack DW. et al. Validation of self-reported breast and cervical cancer screening tests among low-income minority women. Cancer Epidemiol Biomarkers Prev 1996;5:721–6
   PubMed Web of Science ®Google Scholar
• Suarez L, Goldman DA, Weiss NS. Validity of Pap smear and mammogram self-reports in a low-income Hispanic population. Am J Prev Med 1995;11:94–823. Suarez L, Goldman DA, Weiss NS. Validity of Pap smear and mammogram self-reports in a low-income Hispanic population. Am J Prev Med 1995;11:94–8
   PubMed Web of Science ®Google Scholar
• Limaye A, Connor AJ, Huang X. et al. Comparative analysis of conventional Papanicolaou tests and a fluid-based thin-layer method. Arch Pathol Lab Med 2003 Feb;127:200–424. Limaye A, Connor AJ, Huang X. et al. Comparative analysis of conventional Papanicolaou tests and a fluid-based thin-layer method. Arch Pathol Lab Med 2003 Feb;127:200–4
   PubMed Web of Science ®Google Scholar
• Quest Diagnostics 2003. Annual Report. February 26, 2004. Online: http://media.corporate-ir.net/media_files/NYS/DGX/reports/2003AR/03AR_2.pdf [Last accessed March 19, 2007]25. Quest Diagnostics 2003. Annual Report. February 26, 2004. Online: http://media.corporate-ir.net/media_files/NYS/DGX/reports/2003AR/03AR_2.pdf [Last accessed March 19, 2007]
   Google Scholar
• Hsia J, Kemper E, Kiefe C. et al. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev Med 2000;31:261–7026. Hsia J, Kemper E, Kiefe C. et al. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev Med 2000;31:261–70
   PubMed Web of Science ®Google Scholar